查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1350969

醫藥品臨床研究委外機構 (CRO) 的全球市場:2023-2033年

Contract Research Organisations (CROs) Market Report 2023-2033
出版日期: | 出版商: Visiongain | 英文 353 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2033 年，全球合約研究組織 (CRO) 市場規模將以 10.6% 的複合年增長率成長。

生物製藥市場呈現成長趨勢。生物技術、製藥和醫療器材產業正在不斷擴張，以滿足人口老化日益增長的醫療保健需求。因此，對有效臨床試驗以確保產品功效和安全性的需求也不斷增長。全球約有 266,000 項已發表的臨床試驗正在進行中。光是在美國，目前就有超過 105,000 項已發表的臨床試驗正在進行中。

全球罕見疾病的負擔正在增加，促使藥物和創新的增加。每年只有一小部分晚期罕見疾病患者接受初步治療，其中超過 90% 的患者正在等待治療批准。根據美國疾病管制與預防中心 (CDC) 的報告，到 2021 年，將有 4.75 億人，即世界人口的近 10%，患有一種罕見疾病。預計未來五年將有1520萬人接受罕見疾病臨床基因檢測。此外，越來越多的國家正在推出政府計劃來支持罕見疾病患者。

本報告提供全球醫藥品臨床研究委外機構 (CRO) 的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場概要

  • 主要調查結果
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • COVID-19影響分析
  • 波特的五力分析
  • SWOT分析
  • PEST分析
  • 製藥產業大流行病的最高潮怎麼適應了？
  • CRO採用M&A的理由呢？

第4章 醫藥品臨床研究委外機構 (CRO) 市場分析:各類服務

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 前臨床
  • 臨床
    • 階段I
    • 階段II
    • 階段Ⅲ
    • 階段IV
  • 化驗服務
  • 諮詢服務
  • 資料管理服務

第5章 醫藥品臨床研究委外機構 (CRO) 市場分析:不同企業規模

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 大規模企業
  • 中規模
  • 小規模

第6章 醫藥品臨床研究委外機構 (CRO) 市場分析:醫藥品各類型

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 低分子
  • 高分子

第7章 醫藥品臨床研究委外機構 (CRO) 市場分析:各治療領域

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 腫瘤
  • 中樞神經系統
  • 心臟病
  • 感染性
  • 代謝
  • 其他

第8章 醫藥品臨床研究委外機構 (CRO) 市場分析:各地區

  • 主要調查結果
  • 市場規模的估計·預測

第9章 北美的醫藥品臨床研究委外機構 (CRO) 市場分析

第10章 歐洲的醫藥品臨床研究委外機構 (CRO) 市場分析

第11章 亞太地區的醫藥品臨床研究委外機構 (CRO) 市場分析

第12章 南美的醫藥品臨床研究委外機構 (CRO) 市場分析

第13章 中東·非洲的醫藥品臨床研究委外機構 (CRO) 市場分析

第14章 企業簡介

  • 競爭情形
  • Charles River Laboratories
  • CMIC HOLDINGS Co., Ltd.
  • Caidya
  • ICON plc
  • IQVIA Inc.
  • Labcorp Drug Development
  • Medpace
  • Parexel International(MA)Corporation
  • Thermo Fisher Scientific Inc.(PPD)
  • Syneos Health
  • Worldwide Clinical Trials
  • Wuxi AppTec
  • Eurofins Scientific
  • Evotec SE
  • Allucent
  • Syngene International
  • Anthem Biosciences Private Limited
  • The Emmes Company, LLC
  • Bio-Techne
  • Inotiv
  • Frontage Labs.

第15章 總論·建議

Product Code: PHA1273

The global Contract Research Organisations (CROs) market is projected to grow at a CAGR of 10.6% by 2033.

“The Contract Research Organisations (CROs) Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The market for biopharmaceuticals is rising, there is an increase in the need for healthcare due to an ageing population, and the biotech, pharmaceutical, and medical device industries are expanding to fulfil this demand. As a result, the demand for effective clinical studies has increased in order to ensure the efficacy and safety of products. Worldwide, there are around 266 thousand open clinical trials ongoing. More than 105,000 open clinical investigations are now being conducted just in the United States.

The burden of uncommon diseases is increasing internationally, which has led to an increase and innovation in the creation of medicines. While it is still true that only a small portion of terminal rare diseases receive their initial treatment each year and that over 90% of these diseases await therapy approval. In 2021, the CDC reported that 475 million individuals, or nearly 10% of the world's population, were thought to be living with a rare disease. 15.2 million Individuals are predicted to receive clinical genetic testing for a rare disease during the course of the next five years. A rising number of nations are putting in place government programs to assist people with rare illnesses.

Intellectual Property Issues Likely to Challenge Industry Growth

Intellectual property is one of the key barriers to outsourcing clinical trials, which might restrict the expansion of contract research organisations' markets. Because copyrighted products make up the majority of therapeutic candidates, a contract research organisation may increase the danger of data leaks.

Additionally, pharmaceutical companies that develop novel medicines are expected to provide clinical data about safety and efficacy to the relevant governmental and regulatory bodies in order for their treatments to be approved. As a result, the guidelines for pre- and post-grant disagreement as well as issues pertaining to the patent are quite strict. However, it improves the efficiency of inspection and has assisted in the cancellation of patents. It is crucial to focus more emphasis on clinical trial agreements since the government thoroughly evaluates clinical trial-related issues as well. However, these issues harm the CRO's reputation and may stop the sector for contract research organisations from expanding.

What Questions Should You Ask Before Buying a Market Research Report?

  • How is the contract research organisations (CROs) market evolving?
  • What is driving and restraining the contract research organisations (CROs) market?
  • How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each contract research organisations (CROs) submarket develop from 2022 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading contract research organisations (CROs) markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the contract research organisations (CROs) projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of contract research organisations (CROs) projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the contract research organisations (CROs) market?
  • Where is the contract research organisations (CROs) market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Contract Research Organisations (CROs) market today, and over the next 10 years:

  • Our 353-page report provides 141 tables, 201 charts, and graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Contract Research Organisations (CROs) market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Contract Research Organisations (CROs) prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Service

  • Preclinical
  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Laboratory Services
  • Consulting Services
  • Data Management Services

Company Size

  • Large Pharma & Biotech Companies
  • Mid-sized Pharma & Biotech Companies
  • Small Pharma & Biotech Companies

Drug Type

  • Small Molecules
  • Large Molecules

Therapeutic Area

  • Oncology
  • CNS
  • Cardiology
  • Infectious
  • Metabolic
  • Other Therapeutic Area

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Egypt
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Contract Research Organisations (CROs) Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Allucent
  • Anthem Biosciences Private Limited
  • Bio-Techne
  • Charles River Laboratories
  • Caidya
  • CMIC HOLDINGS Co., Ltd
  • Eurofins Scientific
  • Evotec SE
  • Frontage Labs
  • ICON plc
  • Inotiv
  • IQVIA Inc.
  • Labcorp Drug Development
  • Medpace
  • Parexel International (MA) Corporation
  • PPD (Thermo Fisher Scientific Inc.)
  • Syneos Health
  • Syngene International Limited
  • The Emmes Company, LLC
  • Worldwide Clinical Trials
  • Wuxi AppTec

Overall world revenue for Contract Research Organisations (CROs) Market, 2023 to 2033 in terms of value the market will surpass US$68 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Contract Research Organisations (CROs) Market, 2023 to 2033 report help you?

In summary, our 350+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Contract Research Organisations (CROs) Market, 2023 to 2033, with forecasts for services, company size, drug type, and therapeutic area, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 25 key national markets - See forecasts for the Contract Research Organisations (CROs) Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, Argentina, GCC, South Africa, and Egypt among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 21 of the major companies involved in the Contract Research Organisations (CROs) Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Contract Research Organisations (CROs) Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Contract Research Organisations (CROs) Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Demand for Clinical Trials Globally
      • 3.2.1.2 Growing Disease Burden Globally to Fuel CROs Market Growth
      • 3.2.1.3 Rising R&D Investments by Pharmaceutical and Biotech Companies to Boost CROs Market Growth
      • 3.2.1.4 Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth
      • 3.2.1.5 High Cost of In-house Drug Development
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Intellectual Property Issues May Hamper CROs Industry Growth
      • 3.2.2.2 Shortage of Skilled Labour Post COVID-19 Hampering CRO Industry
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Applications of Artificial Intelligence Could Lead to Faster, Safer and Significantly Less Expensive Clinical Trials
      • 3.2.3.2 Increasing Demand for Biological Therapies to Offer Lucrative Growth Prospects for CROs
      • 3.2.3.3 Growth in Nuclear Medicine Sector
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Competitive Rivalry: High
    • 3.4.2 Threat of New Entrants: Low to Medium
    • 3.4.3 Threat of Substitutes: Low to Medium
    • 3.4.4 Bargaining Power of Buyers: Medium to High
    • 3.4.5 Bargaining Power of Suppliers: Medium to High
  • 3.5 SWOT Analysis
  • 3.6 PEST Analysis
  • 3.7 How has the Pharmaceutical Industry Adapted Amidst the Pandemic?
  • 3.8 Why are CROs Adopting Mergers & Acquisitions?

4 Contract Research Organisations (CROs) Market Analysis by Services

  • 4.1 Key Findings
  • 4.2 Services Segment: Market Attractiveness Index
  • 4.3 Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
  • 4.4 Preclinical
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Clinical
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.3 Phase I
      • 4.5.3.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.5.3.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.4 Phase II
      • 4.5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.5.4.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.5 Phase III
      • 4.5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.5.5.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.6 Phase IV
      • 4.5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Laboratory Services
    • 4.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.7 Consulting Services
    • 4.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.8 Data Management Services
    • 4.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.8.2 Market Share by Region, 2023 & 2033 (%)

5 Contract Research Organisations (CROs) Market, by Company Size, 2023-2033

  • 5.1 Key Findings
  • 5.2 Company Size Segment: Market Attractiveness Index
  • 5.3 Contract Research Organisations (CROs) Market, by Company Size
  • 5.4 Large Pharma & Biotech Companies
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Mid-sized Pharma & Biotech Companies
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Small Pharma & Biotech Companies
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Contract Research Organisations (CROs) Market, by Drug Type, 2023-2033

  • 6.1 Key Findings
  • 6.2 Drug Type Segment: Market Attractiveness Index
  • 6.3 Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
  • 6.4 Small Molecules
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Large Molecules
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Contract Research Organisations (CROs) Market, by Therapeutic Area, 2023-2033

  • 7.1 Key Findings
  • 7.2 Therapeutic Area Segment: Market Attractiveness Index
  • 7.3 Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
  • 7.4 Oncology
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 CNS
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Cardiology
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Infectious
    • 7.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)
  • 7.8 Metabolic
    • 7.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.8.2 Market Share by Region, 2023 & 2033 (%)
  • 7.9 Other Therapeutic Area
    • 7.9.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.9.2 Market Share by Region, 2023 & 2033 (%)

8 Contract Research Organisations (CROs) Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Contract Research Organisations (CROs) Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Contract Research Organisations (CROs) Market Attractiveness Index
  • 9.3 North America Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 9.4 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
  • 9.5 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
  • 9.6 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
  • 9.7 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
  • 9.8 North America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
  • 9.9 U.S. Contract Research Organisations (CROs) Market Analysis
  • 9.10 Canada Contract Research Organisations (CROs) Market Analysis

10 Europe Contract Research Organisations (CROs) Market, 2023-2033

  • 10.1 Key Findings
  • 10.2 Europe Contract Research Organisations (CROs) Market Attractiveness Index
  • 10.3 Europe Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 10.4 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
  • 10.5 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
  • 10.6 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
  • 10.7 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
  • 10.8 Europe Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
  • 10.9 Germany Contract Research Organisations (CROs) Market Analysis
  • 10.10 UK Contract Research Organisations (CROs) Market Analysis
  • 10.11 France Contract Research Organisations (CROs) Market Analysis
  • 10.12 Italy Contract Research Organisations (CROs) Market Analysis
  • 10.13 Spain Contract Research Organisations (CROs) Market Analysis
  • 10.14 Switzerland Contract Research Organisations (CROs) Market Analysis
  • 10.15 Netherlands Contract Research Organisations (CROs) Market Analysis
  • 10.16 Rest of Europe Contract Research Organisations (CROs) Market Analysis

11 Asia Pacific Contract Research Organisations (CROs) Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Contract Research Organisations (CROs) Market Attractiveness Index
  • 11.3 Asia Pacific Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 11.4 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
  • 11.6 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
  • 11.7 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
  • 11.8 Asia Pacific Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
  • 11.9 Japan Contract Research Organisations (CROs) Market Analysis
  • 11.10 China Contract Research Organisations (CROs) Market Analysis
  • 11.11 India Contract Research Organisations (CROs) Market Analysis
  • 11.12 Australia Contract Research Organisations (CROs) Market Analysis
  • 11.13 South Korea Contract Research Organisations (CROs) Market Analysis
  • 11.14 Singapore Contract Research Organisations (CROs) Market Analysis
  • 11.15 Rest of Asia Pacific Contract Research Organisations (CROs) Market Analysis

12 Latin America Contract Research Organisations (CROs) Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Contract Research Organisations (CROs) Market Attractiveness Index
  • 12.3 Latin America Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 12.4 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
  • 12.5 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
  • 12.6 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
  • 12.7 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
  • 12.8 Latin America Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
  • 12.9 Brazil Contract Research Organisations (CROs) Market Analysis
  • 12.10 Mexico Contract Research Organisations (CROs) Market Analysis
  • 12.11 Argentina Contract Research Organisations (CROs) Market Analysis
  • 12.12 Rest of Latin America Contract Research Organisations (CROs) Market Analysis

13 MEA Contract Research Organisations (CROs) Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Contract Research Organisations (CROs) Market Attractiveness Index
  • 13.3 MEA Contract Research Organisations (CROs) Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 13.4 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Country
  • 13.5 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Services
  • 13.6 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Company Size
  • 13.7 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Drug Type
  • 13.8 MEA Contract Research Organisations (CROs) Market Size Estimation and Forecast by Therapeutic Area
  • 13.9 GCC Contract Research Organisations (CROs) Market Analysis
  • 13.10 South Africa Contract Research Organisations (CROs) Market Analysis
  • 13.11 Egypt Contract Research Organisations (CROs) Market Analysis
  • 13.12 Rest of MEA Contract Research Organisations (CROs) Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2022
  • 14.2 Charles River Laboratories
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2018-2022
      • 14.2.3.2 Segment Market Shares, 2022
      • 14.2.3.3 Regional Market Shares, 2022
    • 14.2.4 Service Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 CMIC HOLDINGS Co., Ltd.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2018-2022
      • 14.3.3.2 Segment Market Shares, 2022
    • 14.3.4 Service Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Caidya
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Service Benchmarking
    • 14.4.4 Strategic Outlook
  • 14.5 ICON plc
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2018-2022
      • 14.5.3.2 Regional Market Shares, 2022
    • 14.5.4 Service Benchmarking
    • 14.5.5 Strategic Outlook
  • 14.6 IQVIA Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2018-2022
      • 14.6.3.2 Segment Market Shares, 2022
      • 14.6.3.3 Regional Market Shares, 2022
    • 14.6.4 Service Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Labcorp Drug Development
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2018-2022
      • 14.7.3.2 Segment Market Shares, 2022
      • 14.7.3.3 Regional Market Shares, 2022
    • 14.7.4 Service Benchmarking
    • 14.7.5 Strategic Outlook
  • 14.8 Medpace
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2018-2022
      • 14.8.3.2 Segment Market Shares, 2022
    • 14.8.4 Service Benchmarking
  • 14.9 Parexel International (MA) Corporation
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Service Benchmarking
    • 14.9.4 Strategic Outlook
  • 14.10 Thermo Fisher Scientific Inc. (PPD)
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2018-2022
      • 14.10.3.2 R&D, 2018-2022
      • 14.10.3.3 Segment Market Shares, 2022
      • 14.10.3.4 Regional Market Shares, 2022
    • 14.10.4 Service Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Syneos Health
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2018-2022
      • 14.11.3.2 Segment Market Shares, 2022
      • 14.11.3.3 Regional Market Shares, 2022
    • 14.11.4 Service Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Worldwide Clinical Trials
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Service Benchmarking
    • 14.12.4 Strategic Outlook
  • 14.13 Wuxi AppTec
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2018-2022
      • 14.13.3.2 Segment Market Shares, 2022
      • 14.13.3.3 Regional Market Shares, 2022
    • 14.13.4 Service Benchmarking
    • 14.13.5 Strategic Outlook
  • 14.14 Eurofins Scientific
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2018-2022
      • 14.14.3.2 Segment Market Shares, 2022
      • 14.14.3.3 Regional Market Shares, 2022
    • 14.14.4 Service Benchmarking
    • 14.14.5 Strategic Outlook
  • 14.15 Evotec SE
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2018-2022
      • 14.15.3.2 R&D, 2018-2022
      • 14.15.3.3 Regional Market Shares, 2022
    • 14.15.4 Service Benchmarking
    • 14.15.5 Strategic Outlook
  • 14.16 Allucent
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Service Benchmarking
    • 14.16.4 Strategic Outlook
  • 14.17 Syngene International
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Financial Analysis
      • 14.17.3.1 Net Revenue, 2018-2022
      • 14.17.3.2 Regional Market Shares, 2022
    • 14.17.4 Service Benchmarking
    • 14.17.5 Strategic Outlook
  • 14.18 Anthem Biosciences Private Limited
    • 14.18.1 Company Snapshot
    • 14.18.2 Company Overview
    • 14.18.3 Service Benchmarking
  • 14.19 The Emmes Company, LLC
    • 14.19.1 Company Snapshot
    • 14.19.2 Company Overview
    • 14.19.3 Service Benchmarking
    • 14.19.4 Strategic Outlook
  • 14.20 Bio-Techne
    • 14.20.1 Company Snapshot
    • 14.20.2 Company Overview
    • 14.20.3 Financial Analysis
      • 14.20.3.1 Net Revenue, 2018-2022
      • 14.20.3.2 R&D, 2018-2022
      • 14.20.3.3 Segment Market Shares, 2022
      • 14.20.3.4 Regional Market Shares, 2022
    • 14.20.4 Service Benchmarking
    • 14.20.5 Strategic Outlook
  • 14.21 Inotiv
    • 14.21.1 Company Snapshot
    • 14.21.2 Company Overview
    • 14.21.3 Financial Analysis
      • 14.21.3.1 Net Revenue, 2018-2022
      • 14.21.3.2 Segment Market Shares, 2022
      • 14.21.3.3 Regional Market Shares, 2022
    • 14.21.4 Service Benchmarking
    • 14.21.5 Strategic Outlook
  • 14.22 Frontage Labs.
    • 14.22.1 Company Snapshot
    • 14.22.2 Company Overview
    • 14.22.3 Financial Analysis
      • 14.22.3.1 Net Revenue, 2018-2022
      • 14.22.3.2 R & D, 2018-2022
      • 14.22.3.3 Segment Market Shares, 2022
      • 14.22.3.4 Regional Market Shares, 2022
    • 14.22.4 Service Benchmarking
    • 14.22.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Contract Research Organisations (CROs) Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
  • Table 2 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 7 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 8 Clinical Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 9 Phase I Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 10 Phase II Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 11 Phase III Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 12 Phase IV Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 13 Laboratory Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 14 Consulting Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 15 Data Management Services Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 16 Contract Research Organisations (CROs) Market by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 17 Large Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 18 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 19 Small Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 20 Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 21 Small Molecules Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 22 Large Molecules Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 23 Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 24 Oncology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 25 CNS Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 26 Cardiology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 27 Infectious Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 28 Metabolic Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 29 Other Therapeutic Area Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 30 Contract Research Organisations (CROs) Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 31 North America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 32 North America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 34 North America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 35 North America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 36 U.S. Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 37 Canada Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 38 Europe Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 39 Europe Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 40 Europe Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 41 Europe Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 42 Europe Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 43 Germany Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 44 UK Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 45 France Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 46 Italy Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 47 Spain Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 48 Switzerland Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 49 Netherlands Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 50 Rest of Europe Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 51 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 52 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 53 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 54 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 55 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 56 Japan Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 57 China Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 58 India Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 59 Australia Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 60 South Korea Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 61 Singapore Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 62 Rest of Asia Pacific Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 63 Latin America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 64 Latin America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 65 Latin America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 66 Latin America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 67 Latin America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 68 Brazil Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 69 Mexico Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 70 Argentina Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 71 Rest of Latin America Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 72 MEA Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 73 MEA Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 74 MEA Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 75 MEA Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 76 MEA Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 77 GCC Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 78 South Africa Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 79 Egypt Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 80 Rest of MEA Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 81 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Charles River Laboratories: Service Benchmarking
  • Table 83 Charles River Laboratories: Strategic Outlook
  • Table 84 CMIC HOLDINGS Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 CMIC HOLDINGS Co., Ltd.: Service Benchmarking
  • Table 86 CMIC HOLDINGS Co., Ltd.: Strategic Outlook
  • Table 87 Caidya: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Caidya: Service Benchmarking
  • Table 89 Caidya: Strategic Outlook
  • Table 90 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 ICON plc: Service Benchmarking
  • Table 92 ICON plc: Strategic Outlook
  • Table 93 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 IQVIA Inc.: Service Benchmarking
  • Table 95 IQVIA Inc.: Strategic Outlook
  • Table 96 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Labcorp Drug Development: Service Benchmarking
  • Table 98 Labcorp Drug Development: Strategic Outlook
  • Table 99 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Medpace: Service Benchmarking
  • Table 101 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Parexel International (MA) Corporation.: Service Benchmarking
  • Table 103 Parexel International (MA) Corporation.: Strategic Outlook
  • Table 104 Thermo Fisher Scientific Inc. (PPD): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Thermo Fisher Scientific Inc. (PPD): Service Benchmarking
  • Table 106 Thermo Fisher Scientific Inc. (PPD): Strategic Outlook
  • Table 107 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Syneos Health: Service Benchmarking
  • Table 109 Syneos Health: Strategic Outlook
  • Table 110 Worldwide Clinical Trials: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Worldwide Clinical Trials: Service Benchmarking
  • Table 112 Worldwide Clinical Trials: Strategic Outlook
  • Table 113 Wuxi AppTec : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Wuxi AppTec : Service Benchmarking
  • Table 115 Wuxi AppTec : Strategic Outlook
  • Table 116 Eurofins Scientific.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 Eurofins Scientific.: Service Benchmarking
  • Table 118 Eurofins Scientific.: Strategic Outlook
  • Table 119 Evotec SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 Evotec SE: Service Benchmarking
  • Table 121 Evotec SE: Strategic Outlook
  • Table 122 Allucent : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 Allucent: Service Benchmarking
  • Table 124 Allucent: Strategic Outlook
  • Table 125 Syngene International : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 126 Syngene International: Service Benchmarking
  • Table 127 Syngene International: Strategic Outlook
  • Table 128 Anthem Biosciences Private Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 129 Anthem Biosciences Private Limited: Service Benchmarking
  • Table 130 The Emmes Company, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 The Emmes Company, LLC: Service Benchmarking
  • Table 132 The Emmes Company, LLC: Strategic Outlook
  • Table 133 Bio-Techne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 134 Bio-Techne: Service Benchmarking
  • Table 135 Bio-Techne: Strategic Outlook
  • Table 136 Inotiv: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 137 Inotiv: Service Benchmarking
  • Table 138 Inotiv: Strategic Outlook
  • Table 139 Frontage Labs.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 140 Frontage Labs.: Service Benchmarking
  • Table 141 Frontage Labs.: Strategic Outlook
  •  

List of Figures

  • Figure 1 Contract Research Organisations (CROs) Market Segmentation
  • Figure 2 Contract Research Organisations (CROs) Market Attractiveness Index by Region
  • Figure 3 Contract Research Organisations (CROs) Market by Services: Market Attractiveness Index
  • Figure 4 Contract Research Organisations (CROs) Market by Company Size: Market Attractiveness Index
  • Figure 5 Contract Research Organisations (CROs) Market by Drug Type: Market Attractiveness Index
  • Figure 6 Contract Research Organisations (CROs) Market by Therapeutic Area: Market Attractiveness Index
  • Figure 7 Contract Research Organisations (CROs) Market: Market Dynamics
  • Figure 8 Number of Clinical Trials Listed in the WHO International Clinical Trials Registry Platform, by Region, 2020-2022
  • Figure 9 R&D Spending of Large Pharmaceutical Companies in $ Billion, 2022
  • Figure 10 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 11 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 12 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 13 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 14 Contract Research Organisations (CROs) Market: Porter's Five Forces Analysis
  • Figure 15 Contract Research Organisations (CROs) Market: SWOT Analysis
  • Figure 16 Contract Research Organisations (CROs) Market: PEST Analysis
  • Figure 17 Contract Research Organisations (CROs) Market by Services: Market Attractiveness Index
  • Figure 18 Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR %)
  • Figure 19 Contract Research Organisations (CROs) Market Share Forecast by Service, 2023, 2028, 2033 (%)
  • Figure 20 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 21 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Clinical Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 23 Clinical Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 Phase I Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 25 Phase I Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 Phase II Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 27 Phase II Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Phase III Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 29 Phase III Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Phase IV Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 31 Phase IV Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 32 Laboratory Services Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 33 Laboratory Services Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 Consulting Services Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 35 Consulting Services Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Data Management Services Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 37 Data Management Services Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Contract Research Organisations (CROs) Market by Application: Market Attractiveness Index
  • Figure 39 Contract Research Organisations (CROs) Market by Company Size, 2023-2033 (US$ Billion)
  • Figure 40 Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023, 2028, 2033 (%)
  • Figure 41 Large Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 42 Large Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 43 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 44 Mid-sized Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Small Pharma & Biotech Companies Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 46 Small Pharma & Biotech Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 Contract Research Organisations (CROs) Market by Drug Type: Market Attractiveness Index
  • Figure 48 Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
  • Figure 49 Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023, 2028, 2033 (%)
  • Figure 50 Small Molecules Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 51 Small Molecules Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 52 Large Molecules Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 53 Large Molecules Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 54 Contract Research Organisations (CROs) Market by Therapeutic Area: Market Attractiveness Index
  • Figure 55 Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
  • Figure 56 Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
  • Figure 57 Oncology Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 58 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 59 CNS Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 60 CNS Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 61 Cardiology Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 62 Cardiology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 63 Infectious Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 64 Infectious Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 65 Metabolic Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 66 Metabolic Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 67 Other Therapeutic Area Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 68 Other Therapeutic Area Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 69 Contract Research Organisations (CROs) Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
  • Figure 70 Contract Research Organisations (CROs) Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 71 Contract Research Organisations (CROs) Market by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 72 North America Contract Research Organisations (CROs) Market Attractiveness Index
  • Figure 73 North America Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 74 North America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
  • Figure 75 North America Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 76 North America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion, AGR %)
  • Figure 77 North America Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 78 North America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion, AGR %)
  • Figure 79 North America Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 80 North America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
  • Figure 81 North America Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 82 North America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion, AGR %)
  • Figure 83 North America Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 84 U.S. Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 85 Canada Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 86 Europe Contract Research Organisations (CROs) Market Attractiveness Index
  • Figure 87 Europe Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 88 Europe Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 89 Europe Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 90 Europe Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
  • Figure 91 Europe Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 92 Europe Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
  • Figure 93 Europe Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 94 Europe Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
  • Figure 95 Europe Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033(%)
  • Figure 96 Europe Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
  • Figure 97 Europe Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033(%)
  • Figure 98 Germany Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 99 UK Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 100 France Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 101 Italy Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 102 Spain Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 103 Switzerland Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 104 Netherlands Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 105 Rest of Europe Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 106 Asia Pacific Contract Research Organisations (CROs) Market Attractiveness Index
  • Figure 107 Asia Pacific Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 108 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 109 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 110 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
  • Figure 111 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 112 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
  • Figure 113 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 114 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
  • Figure 115 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 116 Asia Pacific Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
  • Figure 117 Asia Pacific Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 118 Japan Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 119 China Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 120 India Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 121 Australia Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 122 South Korea Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 123 Singapore Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 124 Rest of Asia Pacific Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 125 Latin America Contract Research Organisations (CROs) Market Attractiveness Index
  • Figure 126 Latin America Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 127 Latin America Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 128 Latin America Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 129 Latin America Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
  • Figure 130 Latin America Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 131 Latin America Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
  • Figure 132 Latin America Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 133 Latin America Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
  • Figure 134 Latin America Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 135 Latin America Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
  • Figure 136 Latin America Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 137 Brazil Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 138 Mexico Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 139 Argentina Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 140 Rest of Latin America Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 141 MEA Contract Research Organisations (CROs) Market Attractiveness Index
  • Figure 142 MEA Contract Research Organisations (CROs) Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 143 MEA Contract Research Organisations (CROs) Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 144 MEA Contract Research Organisations (CROs) Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 145 MEA Contract Research Organisations (CROs) Market Forecast by Services, 2023-2033 (US$ Billion)
  • Figure 146 MEA Contract Research Organisations (CROs) Market Share Forecast by Services, 2023 & 2033 (%)
  • Figure 147 MEA Contract Research Organisations (CROs) Market Forecast by Company Size, 2023-2033 (US$ Billion)
  • Figure 148 MEA Contract Research Organisations (CROs) Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 149 MEA Contract Research Organisations (CROs) Market Forecast by Drug Type, 2023-2033 (US$ Billion)
  • Figure 150 MEA Contract Research Organisations (CROs) Market Share Forecast by Drug Type, 2023 & 2033 (%)
  • Figure 151 MEA Contract Research Organisations (CROs) Market Forecast by Therapeutic Area, 2023-2033 (US$ Billion)
  • Figure 152 MEA Contract Research Organisations (CROs) Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 153 GCC Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 154 South Africa Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 155 Egypt Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 156 Rest of MEA Contract Research Organisations (CROs) Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 157 Contract Research Organisations (CROs) Market: Company Share/Ranking, 2022
  • Figure 158 Charles River Laboratories: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 159 Charles River Laboratories: Segment Market Shares, 2022
  • Figure 160 Charles River Laboratories: Regional Market Shares, 2022
  • Figure 161 CMIC HOLDINGS Co., Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 162 CMIC HOLDINGS Co., Ltd.: Segment Market Shares -2022
  • Figure 163 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 164 ICON plc: Regional Market Shares, 2022
  • Figure 165 IQVIA Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
  • Figure 166 IQVIA Inc.: Segment Market Shares, 2022
  • Figure 167 IQVIA Inc.: Regional Market Shares, 2022
  • Figure 168 Labcorp Drug Development: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 169 Labcorp Drug Development: Segment Market Shares, 2022
  • Figure 170 Labcorp Drug Development: Regional Market Shares, 2022
  • Figure 171 Medpace: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 172 Medpace: Segment Market Shares, 2022
  • Figure 173 Thermo Fisher Scientific Inc. (PPD): Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 174 Thermo Fisher Scientific Inc. (PPD): R&D, 2018-2022(US$ Million, AGR %)
  • Figure 175 Thermo Fisher Scientific Inc. (PPD): Segment Market Shares, 2022
  • Figure 176 Thermo Fisher Scientific Inc. (PPD): Regional Market Shares, 2022
  • Figure 177 Syneos Health.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 178 Syneos Health.: Segment Market Shares, 2022
  • Figure 179 Syneos Health.: Regional Market Shares, 2022
  • Figure 180 Wuxi AppTec: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 181 Wuxi AppTec : Segment Market Shares, 2022
  • Figure 182 Wuxi AppTec .: Regional Market Shares, 2022
  • Figure 183 Eurofins Scientific.: Net Revenue, 2018-2022(US$ Million, AGR %)
  • Figure 184 Eurofins Scientific.: Segment Market Shares, 2022
  • Figure 185 Eurofins Scientific.: Regional Market Shares, 2022
  • Figure 186 Evotec SE: Net Revenue, 2018-2022(US$ Million, AGR %)
  • Figure 187 Evotec SE: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 188 Evotec SE: Regional Market Shares, 2022
  • Figure 189 Syngene International: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 190 Syngene International: Regional Market Shares, 2022
  • Figure 191 Bio-Techne: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 192 Bio-Techne: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 193 Bio-Techne: Segment Market Shares, 2022
  • Figure 194 Bio-Techne: Regional Market Shares, 2022
  • Figure 195 Inotiv: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 196 Inotiv: Segment Market Shares, 2022
  • Figure 197 Inotiv: Regional Market Shares, 2022
  • Figure 198 Frontage Labs. : Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 199 Frontage Labs.: R & D, 2018-2022 (US$ Million, AGR %)
  • Figure 200 Frontage Labs.: Segment Market Shares, 2022
  • Figure 201 Frontage Labs.: Regional Market Shares, 2022